Evaluation of a variant in the transcription factor 7‐like 2 (<i>TCF7L2</i>) gene and prostate cancer risk in a population‐based study

Abstract

Our findings suggest that this variant in the TCF7L2 gene may be associated with risk of developing more clinically significant disease. These results need to be confirmed, but provide initial evidence that the TCF7L2 gene may alter risk of developing more aggressive prostate cancer.